Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹10,151 Cr₹-2,298 Cr₹-2,780 Cr₹77 Cr₹-1,781 Cr

What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS is ₹10,151 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹10,151 Cr
Mar2025₹-2,298 Cr
Mar2024₹-2,780 Cr
Mar2023₹77 Cr
Mar2022₹-1,781 Cr

How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹10,151 Cr
Positive
Mar2025 ₹-2,298 Cr
Negative
Mar2024 ₹-2,780 Cr
Negative
Mar2023 ₹77 Cr
Positive
Mar2022 ₹-1,781 Cr -

Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹181,755.1 Cr -2.8% -3% 32.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,120.0 Cr -3.2% -5.4% 12% Stock Analytics
DIVIS LABORATORIES ₹253,390.0 Cr 0.7% 3.2% 61.7% Stock Analytics
CIPLA ₹108,497.0 Cr -2.9% -3.3% -10.4% Stock Analytics
MANKIND PHARMA ₹102,650.0 Cr -2.4% 6% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,925.0 Cr -3.3% 4.7% -2.2% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-2.8%

-3%

32.6%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses